Naples Comprehensive Health NCH and Caristo Diagnostics announced that NCH Rooney Heart Institute has become the first hospital in the nation to use both CaRi-Plaque and CaRi-Heart , two AI-powered imaging-based technologies that identify signs of heart disease and predict a patients risk of heart attack up to 10 years before symptoms appear.
This collaboration marks a significant step forward in the use of artificial intelligence to prevent cardiovascular disease, shifting the focus from reacting to heart attacks to stopping them before they happen.
Caristos FDA-cleared CaRi-Plaque technology analyzes coronary CT angiography CCTA scans, the first-line test for patients with chest pain, to identify high-risk plaque that may lead to future heart attacks. CaRi-Heart is the only technology in the world able to detect and quantify coronary inflammation, an early driver of heart disease, without waiting for patients to develop visible plaque.